Imipenem

The first carbapenem, imipenem-cilastatin (Primaxin), is a chemically stable analogue of thienamycin produced by Streptomyces cattleya. The antibacterial spectrum of imipenem is among the broadest of all of the p-lactam antibiotics. Imipenem is active against most gram-positive, gram-negative, and anaerobic bacteria. When compared with the in vitro activities of third-generation cephalosporins, imipenem is more potent against E. faecalis, B. fragilis, and P. aeruginosa. Imipenem's stability against p-lactamases is attributable to the trans position of the 6-hydroxyethyl side chain on the p-lactam ring. Organisms resistant to imipenem include E. faecium, Stenotrophomonas mal-tophilia, and MRSA.

Imipenem-cilastatin is only available for intramuscular or intravenous administration because oral bioavailability is poor. The enzyme, dehydropeptidase I, present in renal tubules, converts imipenem to an inactive metabolite. To decrease metabolic clearance, imipenem is combined with cilastatin, an inhibitor of dehydropeptidase I. Additional pharmacokinetic information appears in Table 45.2.

Imipenem-cilastatin is one of the drugs of first choice for the empirical therapy of many polymicrobial pulmonary, intraabdominal, and soft tissue infections. The notable adverse effect of imipenem-cilastatin is seizures affecting 1% of patients. Risk factors for seizures are old age, head trauma, previous seizure disorder, cerebrovascular accident, and renal failure. Among patients with a history of penicillin allergy, 10% are cross-sensitive to imipenem-cilastatin.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment